XiaoNing Cai is a seasoned Clinical Program Manager at FibroGen, Inc., with over 12 years of experience in clinical trials spanning phases I to IV. They began their career as a CRA at Jiangsu Nhwa Pharmaceutical Co., Ltd. from 2008 to 2012, and later advanced to Senior CRA and Lead CRA roles at Theorem (now Chiltern) from 2014 to 2015. Since then, XiaoNing has specialized in various therapeutic areas including CNS, cardiovascular, diabetes mellitus, vascular surgery, nephrology, and oncology studies. They graduated with a major in pharmacy before dedicating their career to the pharmaceutical industry and global clinical research organizations.
This person is not in any teams
This person is not in any offices